TrialAntimicrobial agents and chemotherapy2015

In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450.

Tami Pilot-Matias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.